Akio Sato
Founder/CEO
A
AIBIOS
AIBIOS leverages bioinformatics to analyze complex biological data, accelerating the identification of therapeutic candidates for immune diseases. The company addresses the inefficiencies and high costs associated with traditional drug development processes, particularly in the fields of immunology and oncology.
- Biotechnology
Updated 7 months ago
Funding
Raised to date
$7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- AIBIOS leverages bioinformatics to analyze complex biological data, accelerating the identification of therapeutic candidates for immune diseases. The company addresses the inefficiencies and high costs associated with traditional drug development processes, particularly in the fields of immunology and oncology.